NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/23/2023
Back to search
Official data from USPTO
VICORE ALMEE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VICORE ALMEE
ST13
US500000097123429Class
9, 41, 42, 44
Filing
97123429
Registration
7058751
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
05/23/2023
Trademark type
Word
Nice classes
9, 41, 42, 44
Filing date
11/12/2021
Registration date
05/23/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/23/2023
Last transaction
05/23/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Gothenburg, SE
Examiner
RILEY, KATHERINE M
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Vicore Pharma AB
Representatives
Sarah J. Schneider SHERIDAN ROSS P.C.
Technical classification
Nice Classes
Class 9Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software with medical information and content for facilitating the provision of medical advice in the field of depression and anxiety related to Pulmonary Fibrosis; downloadable computer software programs for the administration of scientific content in the nature of analysis of medical data; downloadable computer programsin particular interactive downloadable medical software for treating patients suffering from depression and anxiety related to Pulmonary Fibrosis; downloadable computer software program which is designed to assist patients in reducing and coping with the symptoms of depression and anxiety related to Pulmonary Fibrosis as well as in improving their wellbeing and social occupational functioning and to support health care professionals involved in the treatment of patients with depression and anxiety related to Pulmonary Fibrosis by facilitating the provision of medical advice; downloadable computer application software for websitesmobile telephones and mobile devicessoftware for treating patients suffering from depression and anxiety related to Pulmonary Fibrosis; Downloadable printable educational materials featuring therapeutic medical and counseling contentin the nature of informationformsinstructionschartsstudiesdata and related coaching and advice in the field of depression and anxiety related to Pulmonary Fibrosistreatment of depression and anxiety related to Pulmonary Fibrosisrelated health and wellness; Downloadable electronic publicationsnewsletters and articles for use by medical professionals and patients in the field of depression and anxiety related to Pulmonary Fibrosis
Class 41
Providing of on-line training and continuing education in the nature of virtual lectures in the field of medicinehealth and wellness for users in the medical fields with the aid of software; Educational servicesproviding continuing professional education courseswebinarsseminarsworkshops in the field of medicinehealth and wellness for patients suffering from depression and anxiety related to Pulmonary Fibrosis and for medical personnel specialized on the treatment of depression and anxiety
Class 42
Providing a website featuring digital therapeutic technology that enables users to access resources for treating depression and anxiety related to Pulmonary Fibrosis; providing an online digital therapeutic platform in the nature of providing on-line non-downloadable software for providing behavioral health servicescoachingcounselingadvice in the field of depression and anxiety related to Pulmonary Fibrosis; conducting medical and scientific and technological research in the field of depression and anxiety related to Pulmonary Fibrosis; Scientific and technological servicesconducting technological research and design of digital therapeutics for computer-based interactive and online psychological intervention and counseling in the field of depression and anxiety related to Pulmonary Fibrosis; providing temporary use of non-downloadable computer programs for administration of digital therapeutic and medical content in the field of depression and anxiety related to Pulmonary Fibrosis and the treatment of depression and anxiety related to Pulmonary Fibrosis
Class 44
Therapeutic servicesmedical counsellingpsychological counsellingmedical advice and medical information provided to patients withcare givers treatingdepression and anxiety related to Pulmonary Fibrosis; Providing medical informationcomputer-based interactive medical support servicesin the nature of providing online medical advice for assisting with treatment of patients suffering from depression and anxiety related to Pulmonary Fibrosis and their families; Medical treatment of depression and anxiety by medical personnel
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/23/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/07/2023
PUBO
PUBLISHED FOR OPPOSITION
03/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/01/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/01/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/01/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/01/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/19/2023
GNRT
NON-FINAL ACTION E-MAILED
01/19/2023
CNRT
NON-FINAL ACTION WRITTEN
01/19/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2023
ALIE
ASSIGNED TO LIE
01/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/02/2022
GNRT
NON-FINAL ACTION E-MAILED
09/02/2022
CNRT
NON-FINAL ACTION WRITTEN
09/02/2022
DOCK
ASSIGNED TO EXAMINER
08/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/19/2021
NWAP
NEW APPLICATION ENTERED
11/16/2021
Continuous trademark protection
Get notified about every new filing that threatens VICORE ALMEE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.